top of page

LNCaP Xenograft Model

Rincon Bio offers efficacy studies using the LNCaP Xenograft Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Xenograft
Organ:
Prostate
Derivation:
Lymph node biopsy of a 50yo male prostate carcinomar patient
Mutations:
AR, MEN1, PIK3R1, PTEN, TP53
NCI60:
No
Weeks from stratification to termination (average):
4

LNCaP Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the LNCaP xenograft model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

bottom of page